Exova performed the ASTM D-240, the Standard Test Method for Heat of Combustion, using a Parr Calorimeter. The heat of combustion, as determined by this test method, is designated as one of the chemical and physical requirements of both commercial and military turbine fuels and aviation gasolines.

"It is expected that the Nano Gasoline, since it contains water, would have a lower calorific value. This is reflected by the above results: by calculations it is only about 13.3% less," states Dr. Castano, Chief Innovations Officer of Nano Labs. "As a general rule, the higher the calorific value, the better the mileage. However, we must understand that here we are talking about a novel gasoline-water emulsion, with a surprising high calorific value, comparable to regular gasoline".

The main advantages of using emulsified fuels, instead of the pure fuel itself, are environmental and economic. As one of the different solutions to the problem of world pollution, emulsion fuel technology has received close attention because it may provide better combustion and would contribute to a reduction in emissions. There are also great expectations that it would lead to a reduction in fossil fuel consumption and carbon dioxide emissions on a global level, eventually contributing to providing a final solution to environmental problems, such as effluent gas. It is an established fact that water in the emulsion fuels is shown to improve combustion efficiency and contribute to emission reduction."

"We are very pleased with the favorable evidence the team is building on our Nano Gasoline," states Mr. Chavarria, President of Nano Labs. "We are continuing to run a full suite of ASTM tests against commercial grade gasoline, creating a direct, side-by-side comparison. Again, I stress, it is important to note that we are at the development stage here with a disruptive technology but we are extremely encouraged by these results. We are continuing to work with select partners to continue testing and further our discussions for NG's commercialization."

About Exova

Exova is one of the world's leading dedicated testing groups, trusted by organisations to test and advise on the safety, quality, and performance of their products and operations. With over 90 years of testing, 3,500 global experts, operating in 22 countries, 111 permanent facilities and over 20,000 customers. Exova provide technically demanding testing, calibration and related services across 11 key sectors including food, transportation, industrials, aerospace, oil and gas, fire safety, infrastructure, pharmaceuticals, defense, calibration and environmental. Exova customers include Shell, Honeywell, GE, Siemens and GM, and operates in accordance with national and international standards, having over 1,000 accreditations and approvals. For more information, please visit www.exova.com.

About Nano Labs

Nano Labs Corp. (CTLE) is a nanotechnology research and development company which began during October 2012, but is able to access resources that encompass nearly 30 years of research and development in nanotechnology as well as hundreds of peer-reviewed and published research papers and other scholarly material. The Company's research and development team of scientists, designers, and engineers is focused on creating a portfolio of advanced products that could provide benefits to a variety of industries including: (i) consumer products, (ii) energy, (iii) materials, and (iv) healthcare. Through the use and integration of proprietary nano compounds, our goal is to evolve common products into new, revolutionary products in order to make the world a better place. Nano Labs shares are traded on the OTC Bulletin Board in the United States under the ticker CTLE. For more information, please visit www.NanoLabs.us.

This press release contains forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those laws. These forward-looking statements are based upon a number of assumptions and estimates that are subject to significant uncertainties that involve known and unknown risks, many of which are beyond our control and are not guarantees of future performance. Actual outcomes and results could materially differ from what is expressed, implied, or forecasted in any such forward-looking statements and any such difference may be caused by risk factors listed from time to time in the Company's news releases and/or its filings with the OTC Bulletin Board or as a result of other factors.